LOQTORZI (toripalimab) Injection
LOQTORZI is a prescription medicine used to treat Nasopharyngeal carcinoma (NPC). FDA approved toripalimab (brand name LOQTORZI) is not (yet) registered or available in India but on request Indian patient can buy LOQTORZI at the lowest price.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
LOQTORZI (toripalimab) Injection
Toripalimab-tpzi is a next-generation anti-PD-1 monoclonal antibody that blocks PD-L1 binding to the PD-1 receptor at a unique site with high affinity and activates antitumor immunity demonstrating, in clinical trials, improvement in the overall survival of cancer patients in several tumor types.
LOQTORZI is a medicine that may treat nasopharyngeal cancer by working with your immune system. LOQTORZI can
cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after treatment has ended.
Toripalimab is indicated in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma. It is also indicated as a single agent for adults with recurrent unresectable or metastatic nasopharyngeal carcinoma with disease progression on or after a platinum-containing chemotherapy. Active ingredient: toripalimab-tpzi. Inactive ingredients: citric acid monohydrate, mannitol, polysorbate 80, sodium chloride, sodium citrate, and Water for Injection.
Drug Brand Name: LOQTORZI (toripalimab-tpzi) injection, for intravenous use
Strength: Injection: 240 mg/6 mL (40 mg/mL) solution in a single-dose vial
Current Indication: treat Nasopharyngeal carcinoma (NPC)
Marketed By: Coherus BioSciences, Inc.
Approval Date: 2023
Strength: Injection: 240 mg/6 mL (40 mg/mL) solution in a single-dose vial
Find Reference Updates
- For LOQTORZI (toripalimab) Injection And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- FDA approves toripalimab-tpzi for nasopharyngeal carcinoma
- List ItemToripalimab Becomes First Immunotherapy Drug Approved for Nasopharyngeal Cancer
- How Do Brain Cancer Cells Spread? New Study Finds Clues
- Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
- What is the most important information I should know about LOQTORZI®?
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ LOQTORZI (toripalimab) Injection ”. FDA approved toripalimab (brand name LOQTORZI) is not (yet) registered or available in India but on request Indian patient can buy LOQTORZI at the lowest price. Confirmation of the order for LOQTORZI (toripalimab) Injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to FDA approved toripalimab (brand name LOQTORZI) India.
We have delivered medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
LOQTORZI Sourcing & Delivery
Alleviare India specializes in sourcing and supplying LOQTORZI , a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of LOQTORZI in India.
How much does LOQTORZI cost in the India?
Kindly reach out to us for LOQTORZI (toripalimab) Injection price and availability confirmation.The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import LOQTORZI to India?
To import toripalimab – LOQTORZI, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is LOQTORZI available in India?
LOQTORZI toripalimab is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of LOQTORZI (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for LOQTORZI availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is toripalimab available in India?
Yes, FDA approved toripalimab (brand name LOQTORZI) is not (yet) registered or available in India but on request Indian patient can buy LOQTORZI at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand LOQTORZI (toripalimab) Injection . The import process requires a valid prescription and an Import License in the Patient’s Name.
